Laurel Ranger

Investigators examined whether mandatory disclosure policies and laws have led to a decrease in financial disclosure reporting by physicians.

Excessive numbers of negative clinical trials — many of which may be false-negative trials — are a major impediment to the advancement of critical care medicine.

The FDA has the ability within its governing laws to reveal to the public the reasons for its decisions to reject or approve drugs.

Most deaths related to community-acquired pneumonia that occurred at tertiary-case hospitals were not preventable.

Respiratory pathogens were associated with an increased risk for treatment failure in children with asthma exacerbations.

Barriers to challenge studies include ethical guidelines indicating that the generation of scientific knowledge should never supersede the rights and interests of research subjects.

Although clinical presentation was similar in both community-acquired pneumonia and non-pneumonia exacerbations, CRP, glucose, and leukocytes were higher in the former vs the latter.

A substantial proportion of these individuals diagnosed with HIV, psychiatric disorders, and substance use disorders are out of care and urgently require intervention.

Lung ultrasound was more effective in diagnosing pediatric community-acquired pneumonia than chest radiography.

The investigators suggest that enrollment in a methadone maintenance therapy program may be helpful in providing access to HCV care in people who inject drugs.

A series of reported cases shows that the range of associated clinical manifestations is heterogeneous in chronic nonbacterial osteomyelitis or chronic recurrent multifocal osteomyelitis.

Researchers found increased myocardial infarction rates during the week after Streptococcus pneumoniae and influenza infections.

Adults with community-acquired pneumonia that is visualized on CT scan but not on concurrent chest radiograph have similar pathogens, disease severity, and outcomes as patients who had pneumonia confirmed via chest radiograph.

HIV-positive patients with pulmonary tuberculosis benefited from daily antituberculosis therapy in terms of effectiveness and rifampicin resistance.

Researchers retrospectively analyzed data from patients hospitalized with pneumococcal community-acquired pneumonia to determine risk factors for pneumococcal bacteremia.

Researchers assessed the timing of azithromycin administration for pediatric community-acquired pneumonia to determine its effectiveness in the setting of macrolide resistance.

Prophylactic antibiotics delivered by nebulization in patients who were mechanically ventilated reduced the rate of ventilator-associated pneumonia